Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01936506 · ClinicalTrials.gov registry record · Phase 1

Cognitive Training for Depression

A Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
Phase 1
Development phase
21
Enrollment target

NCT01936506: Completed Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.

NCT01936506 is a Phase 1 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 21 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01936506, a Phase 1 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
Phase 1
Development phase
21 participants
Enrollment target

Study Summary

This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.

Primary Outcome

Change in depression symptom severity at week 4 compared as to baseline

Interventions

  • BEHAVIORAL Cognitive Training A
  • BEHAVIORAL Cognitive Training B

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2010-07
Est. Completion 2012-10
Phase Phase 1

What the finished NCT01936506 record still lists

NCT01936506 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower).

The record links to 0 conditions, and to 2 interventions - of which Cognitive Training A is the first listed.

NCT01936506 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01936506 about?

NCT01936506 is a clinical study titled "Cognitive Training for Depression". This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.

What is the current status of trial NCT01936506?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2010-07. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01936506?

The interventions under investigation include: Cognitive Training A (BEHAVIORAL), Cognitive Training B (BEHAVIORAL).

Who is sponsoring clinical trial NCT01936506?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01936506's enrollment target sits among peer trials

21 1615th of 2000 higher than 372 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01936506, the US trial registry maintained by the National Library of Medicine. NCT01936506 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.